tac01-her2
lonza,triumvira
['tactic-2', 'tac01-her2', 'thank you', 'solid tumor']
thank you to of for expanding on the safety and efficacy of autologous tac01-her2 in relapsed/refractory solid tumors in the phase 1/2 tactic-2 trial. check out for more updates from #asco23! #asco2023 #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.